|
|
Article: Study demonstrates positive results with indiplon immediate release.
- Article from:
- Health & Medicine Week
- Article date:
- April 19, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 APR 19 - (NewsRx.com & NewsRx.net) -- Neurocrine Biosciences, Inc., (NBIX) announced positive results from the pivotal long-term efficacy and safety phase III "RESTFUL" trial with indiplon immediate release in patients with chronic insomnia, achieving highly statistically significant results in sleep initiation and sleep quality that were sustained over a 3-month period.
The study involved 700 adult patients, ages 21-64 years, with chronic insomnia, in which patients received nightly administration of indiplon immediate release (10 mg or 20 mg) over the 3-month period. Results demonstrated that with either of two dose levels of indiplon immediate release, ...